Home Peptide Products PKI 14-22 amide,myristoylated For research use only. Not for use in humans.

PKI 14-22 amide,myristoylated

PKI 14-22 amide, myristoylated is a potent cAMP-dependent PKA inhibitor, which can reduce the IgG-mediated phagocytic response and also inhibits neutrophil adhesion.

Amino-acid Sequence

PKI 14-22 amide,myristoylated Amino-acid Sequence

CAS No. 201422-03-9

Selleck's PKI 14-22 amide,myristoylated has been cited by 1 publication

Purity & Quality Control

Batch: P115401 DMSO] 100 mg/mL] false] Water] 3 mg/mL] false] Ethanol] Insoluble] false Purity: 99.79%
99.79

Chemical Information & Solubility

Storage (From the date of receipt) 3 years-20°C powder

In vitro
Batch:

DMSO : 100 mg/mL ( (82.67 mM)； Moisture-absorbing DMSO reduces solubility. Please use fresh DMSO.)

Water : 3 mg/mL

Ethanol : Insoluble


Molecular Weight Calculator

In vivo
Batch:

Add solvents to the product individually and in order.


In vivo Formulation Calculator

Biological Activity

Description PKI 14-22 amide, myristoylated is a potent cAMP-dependent PKA inhibitor, which can reduce the IgG-mediated phagocytic response and also inhibits neutrophil adhesion.
Targets
PKA

Product Information

Molecular Formula:

C53H100N20O12
Molecular Weight: 1209.49
CAS No.: 201422-03-9
Appearance: White Powder
Peptide Content (by %N): ≥80%
Single Impurity (by HPLC): ≤1.0%
Assay (By Anhydrous, Acetic Acid-free): 95.0~105.0%
MS: Consistent
Packing: plastic vial(dedicated for peptide packing) or glass vial, quantity according to customer's detail requirement.
Storage
(From the date of receipt):		 3 years-20°C powder
Shipping: Room temperature shipping(Stability testing shows this product can be shipped without any cooling measures.)